{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:14:48Z","timestamp":1788318888010,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["KFO5001"],"award-info":[{"award-number":["KFO5001"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clinph.2026.2112341","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:32:07Z","timestamp":1784388727000},"page":"2112341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Autoimmune nodopathies: a clinical review"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-0009","authenticated-orcid":false,"given":"Kathrin","family":"Doppler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7064-5002","authenticated-orcid":false,"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jns.12610","article-title":"Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy","volume":"29","author":"Afanasiev","year":"2024","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000817","article-title":"Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0000000000001195","article-title":"Pan-Neurofascin autoimmune nodopathy - a life-threatening, but reversible neuropathy","volume":"36","author":"Appeltshauser","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.clinph.2026.2112341_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1475478","article-title":"Case report: target antigen and subclass switch in a patient with autoimmune nodopathy","volume":"15","author":"Appeltshauser","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinph.2026.2112341_b0025","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage","author":"Appeltshauser","year":"2022","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0030","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001163","article-title":"Diabetes Mellitus is a possible risk factor for Nodo-paranodopathy with Antiparanodal Autoantibodies","volume":"9","author":"Appeltshauser","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.clinph.2026.2112341_b0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.expneurol.2016.10.006","article-title":"Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins","volume":"287","author":"Appeltshauser","year":"2016","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.clinph.2026.2112341_b0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/acn3.51061","article-title":"Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy","volume":"7","author":"Athanasopoulos","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clinph.2026.2112341_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2025.108856","article-title":"Anti-neurofascin-186 associated combined central and peripheral demyelination (CCPD): a novel entity","volume":"252","author":"Bagchi","year":"2025","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clinph.2026.2112341_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1549363","article-title":"Case Report: Pediatric age onset CNTN1 antibody-associated neuropathy with nephropathy and literature review","volume":"16","author":"Bayraktar Eltutan","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp-2023-331378","article-title":"Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort","volume":"95","author":"Broers","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.27142","article-title":"Long-Term follow up in Anti-Contactin-1 Autoimmune Nodopathy","volume":"97","author":"Caballero-Avila","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinph.2026.2112341_b0065","article-title":"Autoimmune nodopathy with anti-contactin 1 antibody characterized by cerebellar dysarthria: a case report and literature review","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clinph.2026.2112341_b0070","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/NXI.0000000000000238","article-title":"Neurofascin-155 as a putative antigen in combined central and peripheral demyelination","volume":"3","author":"Cortese","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.clinph.2026.2112341_b0080","article-title":"Super-resolution of nodal and paranodal disruption in anti-pan-neurofascin-associated autoimmune nodopathy","volume":"16","author":"da Cruz Neris Gessner V, Linke JT, Peulen TO, Appeltshauser L, Sommer C, Bramer D,","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clinph.2026.2112341_b0085","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000763","article-title":"Antibodies to nodal\/paranodal proteins in paediatric immune-mediated neuropathy","volume":"7","author":"De Simoni","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.clinph.2026.2112341_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","author":"Delmont","year":"2020","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.clinph.2026.2112341_b0095","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.clinph.2026.2112341_b0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2026.2112341_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107521","article-title":"Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy","volume":"223","author":"Dong","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"7","key":"10.1016\/j.clinph.2026.2112341_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134274","article-title":"Contactin-1 and Neurofascin-155\/-186 are not Targets of Auto-Antibodies in Multifocal Motor Neuropathy","volume":"10","author":"Doppler","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 10","key":"10.1016\/j.clinph.2026.2112341_b0115","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.clinph.2026.2112341_b0120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-019-1462-z","article-title":"Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model","volume":"16","author":"Doppler","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.clinph.2026.2112341_b0130","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/jnnp-2018-318170","article-title":"Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies","volume":"89","author":"Doppler","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.clinph.2026.2112341_b0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1083\/jcb.147.6.1145","article-title":"Axo-glial interactions regulate the localization of axonal paranodal proteins","volume":"147","author":"Dupree","year":"1999","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281156","article-title":"Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis","volume":"18","author":"Fehmi","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clinph.2026.2112341_b0145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG(1) pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality","volume":"92","author":"Fehmi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clinph.2026.2112341_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2021-002960","article-title":"Nodal and paranodal antibody-associated neuropathies","author":"Fehmi","year":"2021","journal-title":"Pract. Neurol."},{"issue":"4","key":"10.1016\/j.clinph.2026.2112341_b0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jns.12465","article-title":"Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib","volume":"26","author":"Fels","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"9","key":"10.1016\/j.clinph.2026.2112341_b0160","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2169\/internalmedicine.9286-21","article-title":"Demyelinating Neuropathy with Markedly Elevated Serum IgG4 Levels and Anti-Contactin 1 IgG4 Antibody","volume":"62","author":"Fukushima","year":"2023","journal-title":"Intern. Med."},{"issue":"10","key":"10.1016\/j.clinph.2026.2112341_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16406","article-title":"Proteinuria is a key to suspect autoimmune nodopathies","volume":"31","author":"Funakoshi","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0170","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001056","article-title":"Anti-contactin-1 Antibodies Affect Surface Expression and Sodium Currents in Dorsal root Ganglia","volume":"8","author":"Gr\u00fcner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.clinph.2026.2112341_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1189734","article-title":"Different binding and pathogenic effect of neurofascin and contactin-1 autoantibodies in autoimmune nodopathies","volume":"14","author":"Hecker","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinph.2026.2112341_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.939062","article-title":"Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0185","doi-asserted-by":"crossref","DOI":"10.1111\/jns.12679","article-title":"Ofatumumab for treating autoimmune nodopathy","volume":"30","author":"Hu","year":"2025","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.clinph.2026.2112341_b0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.clinph.2026.2112341_b0195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2026.2112341_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578326","article-title":"Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy","volume":"389","author":"Kmezic","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.clinph.2026.2112341_b0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.clinph.2026.2112341_b0210","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1007\/s00415-024-12597-6","article-title":"IgG subclass shifts occurring at acute exacerbations in autoimmune nodopathies","volume":"271","author":"Kokubun","year":"2024","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.clinph.2026.2112341_b0215","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin. Neurophysiol."},{"issue":"11","key":"10.1016\/j.clinph.2026.2112341_b0220","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.clinph.2026.2112341_b0225","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/mus.28401","article-title":"Paraneoplastic Anti-Contactin-1 Autoimmune Nodopathy","volume":"71","author":"Li","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2026.2112341_b0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ensci.2018.11.016","article-title":"Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Lin","year":"2018","journal-title":"eNeurologicalSci"},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0235","doi-asserted-by":"crossref","DOI":"10.1111\/jns.70000","article-title":"Inter-Laboratory Validation of Nodal\/Paranodal Antibody Testing","volume":"30","author":"Lleixa","year":"2025","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"6","key":"10.1016\/j.clinph.2026.2112341_b0240","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1172\/JCI124694","article-title":"Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"129","author":"Manso","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"Pt 6","key":"10.1016\/j.clinph.2026.2112341_b0245","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0250","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001098","article-title":"Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy","volume":"9","author":"Martin-Aguilar","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0255","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clinph.2026.2112341_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1515161","article-title":"Favorable long-term outcomes of autoimmune nodopathy with mycophenolate mofetil","volume":"15","author":"Min","year":"2024","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/jns.70057","article-title":"Intrathecal Antibody Synthesis in Autoimmune Nodopathy","volume":"30","author":"Min","year":"2025","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.clinph.2026.2112341_b0270","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.clinph.2026.2112341_b0275","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(25)00199-1","article-title":"CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies","volume":"24","author":"Motte","year":"2025","journal-title":"Lancet Neurol."},{"issue":"23","key":"10.1016\/j.clinph.2026.2112341_b0280","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0285","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mus.28239","article-title":"The difference in nerve ultrasound and motor nerve conduction studies between autoimmune nodopathy and chronic inflammatory demyelinating polyneuropathy","volume":"70","author":"Niu","year":"2024","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.clinph.2026.2112341_b0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jneuroim.2014.09.001","article-title":"Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy","volume":"276","author":"Notturno","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clinph.2026.2112341_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577139","article-title":"Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy","volume":"339","author":"Ogata","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0300","first-page":"29","article-title":"A nationwide survey of combined central and peripheral demyelination in Japan","volume":"87","author":"Ogata","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.clinph.2026.2112341_b0305","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"11","key":"10.1016\/j.clinph.2026.2112341_b0310","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/acn3.50931","article-title":"Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody","volume":"6","author":"Ogata","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0315","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s13760-023-02463-z","article-title":"Corticosteroid responsive anti-contactin-1 antibody seropositive chronic inflammatory demyelinating polyneuropathy: report of two cases","volume":"124","author":"Papantoniou","year":"2024","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.clinph.2026.2112341_b0320","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/brain\/awab014","article-title":"Antibodies to the Caspr1\/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"144","author":"Pascual-Goni","year":"2021","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0325","article-title":"Combined Central and Peripheral Demyelination with IgM Anti-Neurofascin 155 Antibodies","volume":"9","author":"Pegat","year":"2022","journal-title":"Case Report. Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.clinph.2026.2112341_b0330","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0335","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0340","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.clinph.2026.2112341_b0345","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200368","article-title":"Clinical Manifestations and Treatment responses in Pediatric Neurofascin 155-IgG4 Autoimmune Nodopathy","volume":"12","author":"Rashed","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0350","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200295","article-title":"Different patterns of Autoantibody Secretion by Peripheral Blood Mononuclear Cells in Autoimmune Nodopathies","volume":"11","author":"Rohrbacher","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"14","key":"10.1016\/j.clinph.2026.2112341_b0355","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.20750","article-title":"Molecular domains of myelinated axons in the peripheral nervous system","volume":"56","author":"Salzer","year":"2008","journal-title":"Glia"},{"issue":"33","key":"10.1016\/j.clinph.2026.2112341_b0360","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1523\/JNEUROSCI.0322-04.2004","article-title":"Contactin associates with sodium channel Nav1.3 in native tissues and increases channel density at the cell surface","volume":"24","author":"Shah","year":"2004","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.clinph.2026.2112341_b0365","doi-asserted-by":"crossref","first-page":"e2392","DOI":"10.1212\/WNL.0000000000012932","article-title":"Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes","volume":"97","author":"Shelly","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0370","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2169\/internalmedicine.2126-23","article-title":"Anti-contactin 1 Antibody-associated Membranous Nephropathy in Chronic Inflammatory Demyelinating Polyneuropathy with Several Autoantibodies","volume":"63","author":"Shida","year":"2024","journal-title":"Intern. Med."},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0375","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0380","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.neuron.2013.03.005","article-title":"Three mechanisms assemble central nervous system nodes of Ranvier","volume":"78","author":"Susuki","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.clinph.2026.2112341_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1021513","article-title":"Effect of monovalency on anti-contactin-1 IgG4","volume":"14","author":"Taieb","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.clinph.2026.2112341_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108883","article-title":"Prevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: a systematic review","volume":"38","author":"Tentolouris","year":"2024","journal-title":"J. Diabetes Complications"},{"issue":"10","key":"10.1016\/j.clinph.2026.2112341_b0395","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin. Neurophysiol."},{"issue":"6","key":"10.1016\/j.clinph.2026.2112341_b0400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp-2017-317192","article-title":"Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground","volume":"89","author":"Uncini","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0405","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jnen\/nlz134","article-title":"Ultrastructural Lesions of Nodo-Paranodopathies in Peripheral Neuropathies","volume":"79","author":"Vallat","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.clinph.2026.2112341_b0410","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/brain\/awy134","article-title":"Subacute nodopathy with conduction blocks and anti-neurofascin 140\/186 antibodies: an ultrastructural study","volume":"141","author":"Vallat","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0415","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.clinph.2026.2112341_b0420","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.clinph.2026.2112341_b0425","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinph.2026.2112341_b0430","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2018.01029","article-title":"Autoantibodies against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance","volume":"9","author":"Vural","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clinph.2026.2112341_b0435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/cjn.2015.238","article-title":"Fulminant Central Plus Peripheral nervous System Demyelination without Antibodies to Neurofascin","volume":"43","author":"Vural","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.clinph.2026.2112341_b0440","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamadermatol.2018.5536","article-title":"Overlap of Bullous, Anti-Laminin-332, and anti-p200 Pemphigoid with Concomitant Anti-Contactin-1-positive Inflammatory Polyneuropathy Treated with Intravenous Immunoglobulins as a Manifestation of Epitope Spreading","volume":"155","author":"Wald","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.clinph.2026.2112341_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578648","article-title":"Proprioceptive endings at muscle spindles as a possible target of autoantibodies","volume":"405","author":"Weigel","year":"2025","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.clinph.2026.2112341_b0450","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2014.09.012","article-title":"Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis","volume":"277","author":"Yan","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clinph.2026.2112341_b0455","article-title":"Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245726008412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245726008412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:40:46Z","timestamp":1788316846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245726008412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":91,"alternative-id":["S1388245726008412"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2026.2112341","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune nodopathies: a clinical review","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2026.2112341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.","name":"copyright","label":"Copyright"}],"article-number":"2112341"}}